Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.50
Delayed Data
As of 4:00pm ET
 0.00 / 0.00%
Today’s Change
2.00
Today|||52-Week Range
7.15
+4.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues30.2M29.7M34.3M40.5M
 
 
 
 
 
Cost of Goods Sold9.0M10.0M10.5M10.5M
 
 
 
 
 
Depreciation And Amortization20.7M18.6M18.2M18.2M
 
 
 
 
 
 
Operating ExpensesGross Income413.0K1.2M5.6M11.7M
 
 
 
 
 
General Expenses26.2M20.8M19.1M20.3M
 
 
 
 
 
Research And Development940.0K528.0K82.0K99.0K
 
 
 
 
 
Total Operating Expenses55.9M49.4M47.8M49.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.7M-19.6M-13.5M-8.7M
 
 
 
 
 
Extraordinary Credit4.9M0.001.2M25.3M
 
 
 
 
Extraordinary Charge-30.0M-800.0K-31.0K-884.0K
 
 
 
 
 
Interest Expense On Debt11.0M9.0M9.2M9.3M
 
 
 
 
 
Other Expenses-23.8M0.000.00-25.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-85.7M-29.4M-21.6M6.4M
 
 
 
 
 
Income Taxes-413.0K-55.0K-40.0K-27.0K
 
 
 
 
 
Net Income-86.1M-29.5M-21.6M6.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.0M10.0M10.0M11.1M
 
 
 
 
 
Shares To Calculate EPS Diluted10.0M10.0M10.0M16.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$8.92-$2.94-$2.16$0.42
 
 
 
 
 
EPS Diluted-$8.59-$2.94-$2.16$0.42